897660-92-3

Basic information

• Product Name: ethyl (+/-)-[6-cyano-3-(methyl-phenyl-carbamoyl)-1,2,3,4-tetrahydro-carbazol-9-yl]-acetate
• Synonyms: ethyl (+/-)-[6-cyano-3-(methyl-phenyl-carbamoyl)-1,2,3,4-tetrahydro-carbazol-9-yl]-acetate
• CAS NO: 897660-92-3
• Molecular Weight: 415.492
• Mol File: 897660-92-3.mol

Chemical Properties

• CAS DataBase Reference: ethyl (+/-)-[6-cyano-3-(methyl-phenyl-carbamoyl)-1,2,3,4-tetrahydro-carbazol-9-yl]-acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (+/-)-[6-cyano-3-(methyl-phenyl-carbamoyl)-1,2,3,4-tetrahydro-carbazol-9-yl]-acetate(897660-92-3)
• EPA Substance Registry System: ethyl (+/-)-[6-cyano-3-(methyl-phenyl-carbamoyl)-1,2,3,4-tetrahydro-carbazol-9-yl]-acetate(897660-92-3)

Safety Data

• Hazardous Substances Data: 897660-92-3(Hazardous Substances Data)

Upstream product

• 897660-90-1 (+/-)-6-cyano-2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid methyl-phenyl-amide 
• 105-36-2 ethyl bromoacetate 

Relevant articles and documents

2,3,4,9- TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS

The invention relates to novel tetrahydro-1H-carbazole derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and methods of treatment comprising administration of said compounds to patients.

2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS

The invention relates to novel tetrahydro-lH-carbazole derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and methods of treatment comprising administration of said compounds to patients.